Ivy Rx vs Push Health
Ivy Rx costs $775 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ivy Rx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Ivy Rx →
If you are choosing between Ivy Rx and Push Health, the first difference is cost: Ivy Rx is $775 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 5.6.
Ivy Rx vs Push Health price
Ivy Rx is the cheaper way in: $175 a month against $950 a month at Push Health. That is $775 less each month (82% lower), or about $9,300 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Ivy Rx ($175 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Ivy Rx lists tirzepatide.
On format, Ivy Rx prices compounded injections, while Push Health prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.
Where each one treats patients
Ivy Rx lists 50 states, and Push Health does not publish where it ships.
Pricing
Ivy Rx
Range up to $197/mo
Range up to $297/mo
Push Health
Ozempic / brand
What each price covers
Ivy Rx's price also covers the clinician visit, the medication itself and shipping, which Push Health does not claim.
Ivy Rx is silent on lab work and coaching.
Push Health does not say what its price includes.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Ivy Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Push Health
Inclusions not disclosed.
Where each one scores higher
Overall, Ivy Rx scores 7.3 and Push Health 5.6 out of 10.
Ivy Rx is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (7.5 vs 4.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.0).
Push Health is stronger on value (5.3 vs 3.0).
Ivy Rx
7.3/10
Push Health
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Ivy Rx nor Push Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Ivy Rx | Push Health |
|---|---|---|
| Starting Price | ✓$175/mo | $950/mo |
| Features | 3 features | ✓5 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Ivy Rx
Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.
Read our full Ivy Rx review →About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →Pros & Cons
Ivy Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Ivy Rx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Ivy Rx wins this one, 7.3 to 5.6, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $775 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Ivy Rx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →Ivy Rx vs Push Health: FAQ
Close alternatives to Ivy Rx and Push Health
- Ivy Rx vs DudeMeds
- Ivy Rx vs Curve
- Ivy Rx vs FitFlow
- Ivy Rx vs Genesis Health
- Push Health vs JumpstartMD
- Push Health vs Marek Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.